|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-23
|
|
pubmed:abstractText |
Multiple daily insulin injection programs are commonly accompanied by considerable glycemic variation and hypoglycemia. We conducted a randomized crossover design clinical trial to compare glargine with ultralente insulin as a basal insulin in type 1 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
10-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15616226-Adult,
pubmed-meshheading:15616226-Aged,
pubmed-meshheading:15616226-Blood Glucose,
pubmed-meshheading:15616226-Diabetes Mellitus, Type 1,
pubmed-meshheading:15616226-Female,
pubmed-meshheading:15616226-Humans,
pubmed-meshheading:15616226-Hypoglycemic Agents,
pubmed-meshheading:15616226-Insulin,
pubmed-meshheading:15616226-Insulin, Long-Acting,
pubmed-meshheading:15616226-Male,
pubmed-meshheading:15616226-Middle Aged,
pubmed-meshheading:15616226-Monitoring, Ambulatory
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes.
|
|
pubmed:affiliation |
Division of Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA. kudva.yogish@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
